+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hemoglobin A1c Testing Devices and Kits Market

  • PDF Icon

    Report

  • 282 Pages
  • September 2023
  • Region: Global
  • BCC Research
  • ID: 5877993

This report aims to provide a comprehensive study of the global market for Hemoglobin A1c Testing Devices & Kits. It describes the different types of Hemoglobin A1c Testing Devices & Kits products, technology, and their current and historical market revenues.

This report discusses the implications of the trends mentioned above in the context of the current size and growth of the diabetes market, in global terms and by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the leading drug and device categories as well as breakdowns of the diabetes market by country.

Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for the Market for Hemoglobin A1c Testing Devices and Kits.

This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific and the Rest of the World. For market estimates, data is provided for 2022 as the base year, 2023, and forecast through year-end 2028.

Report Includes

  • 131 data tables and 46 additional tables
  • An overview of the global market landscape related to the hemoglobin A1c testing devices and kits
  • In-depth analysis of global market trends, featuring historical revenue data for 2020
  • 2022, estimated figures for 2023, as well as forecasts for 2023-2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
  • Evaluation of the current market size and revenue growth prospects specific to hemoglobin A1c testing devices and kits, accompanied by a comprehensive market share analysis categorized by technology, end user, and geographical region
  • Understanding of the upcoming market potential for hemoglobin A1c test devices and kits, and areas of focus to forecast this market into various segments and sub-segments
  • In-depth information (facts and figures) concerning the major factors influencing the progress of this market (benefits, and industry-specific challenges) with respect to specific growth trends, upcoming technologies, regulations, prospects, and contributions to the overall market
  • Discussion of the role and importance of ESG in HbA1c test devices and kits market, consumer attitudes, risks and opportunity assessment, and ESG practices in the industry
  • Identification of the major stakeholders and analysis of their company competitive landscape based on recent developments, key financials and segmental revenues, and operational integration
  • Detailed profiles of leading market participants including Abbott, Siemens Healthineers, Bayer AG, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., and Bio-Rad Laboratories Inc., providing a descriptive overview of their respective businesses

Table of Contents

Chapter 1 Introduction
  • Study Goals and Objectives
  • Reasons for Doing this Study
  • Scope of Report
  • Methodology
  • Secondary Research
  • Primary Interviews
  • Information Sources
  • Geographic Breakdown
Chapter 2 Summary and Highlights
  • Market Outlook
  • Market Summary
Chapter 3 Market Overview
  • Overview
  • What is Diabetes?
  • Types of Diabetes
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes Mellitus (Gdm) or Hyperglycemia in Pregnancy
  • Impaired Glucose Tolerance (Igt) and Impaired Fasting Glucose (Ifg)
  • Epidemiology of Diabetes
  • Gender Distribution
  • Regional Disparities
  • A1C Test
  • Importance of A1C Test
  • Diagnostic Potentials of Hba1C
  • Certified A1C Test Devices
Chapter 4 Market Dynamics
  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
Chapter 5 Global Market for Hemoglobin A1C Testing Devices and Kits by Technology
  • Introduction
  • Chromatography
  • High-Performance Liquid Chromatography (Hplc)
  • Cation-Exchange Hplc
  • Boronate Affinity Chromatography
  • Capillary Electrophoresis (Ce)
  • Assay Techniques
  • Immunoassay
  • Enzymatic Assay
Chapter 6 Global Market for Hemoglobin A1C Testing Devices and Kits by End-user
  • Overview
  • Commercial Laboratories
  • Point of Care Settings
  • Benefits of Poc Testing
  • Poc Testing Applications
  • Hospitals and Clinics
  • Home Care Organizations
  • Other Pocs
Chapter 7 Global Market for Hemoglobin A1C Testing Devices and Kits by Region
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • Italy
  • France
  • United Kingdom
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • India
  • Australia & New Zealand (Anz)
  • China
  • Rest of Asia-Pacific
  • Rest of World
  • Brazil
  • Gcc Countries
  • Other Row Countries
Chapter 8 Sustainability in the Hemoglobin A1C Testing Devices and Kits Industry: An Esg Perspective
  • Importance of Esg in Hemoglobin A1C Testing Devices and Kits Manufacturing Industry
  • Esg Ratings and Metrics: Understanding the Data
  • Future Trends
  • Esg Practices in the Hemoglobin A1C Testing Devices and Kits Manufacturing Industry
  • Environmental Performance
  • Social Performance
  • Governance Performance
  • Case Study
  • Research Viewpoint
Chapter 9 Emerging Technology in the Diabetes Diagnosis Industry: Qualitative Perspective
  • Introduction
  • Emerging Trends in the Diabetes Medical Devices Industry
  • Developments in Hemoglobin A1C Testing Devices and Kits
Chapter 10 M&A and Venture Funding Outlook in the Market
  • M&A Analysis
Chapter 11 Competitive Landscape
Chapter 12 Company Profiles
  • Abbott
  • Arkray Inc.
  • Bayer AG
  • Bio-Rad Laboratories Inc.
  • Danaher
  • Ekf Diagnostics Holdings plc
  • F. Hoffmann-La Roche AG
  • Lumiradx
  • Meril Life Sciences Private. Ltd.
  • Osang Healthcare Co. Ltd.
  • Siemens Healthcare GmbH
  • Sinocare Inc.
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech plc
  • Wuxi Biohermes Biomedical Technology Co. Ltd.
  • Xiamen Biotime Biotechnology Co. Ltd.
Chapter 13 Appendix
  • Government Regulatory Agencies and Professional Organizations
List of Tables
Summary Table: Global Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 1: Key Facts and Latest Data for Diabetes Globally, 2021 and 2045
Table 2: Certified HbA1c Devices and Kits, 2023
Table 3: Global Diabetes Estimates and Projections, 2019-2045
Table 4: Global Prevalence of Diabetes, by Type, Through 2040
Table 5: Diabetic Cases, by Country, 2000-2045
Table 6: Age-Adjusted Comparative Prevalence of Diabetes, by Region, 2010-2040
Table 7: Difference between Traditional Testing and Point-of-Care Testing
Table 8: Global Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 9: HbA1C Method Comparison
Table 10: Global Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography Technology, Through 2028
Table 11: Global Market for Hemoglobin A1c Testing Devices and Kits, by Assay Techniques, Through 2028
Table 12: Global Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 13: Examples of POC Tests
Table 14: Global Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 15: Global Market for Hemoglobin A1c Testing Devices and Kits, by Region, Through 2028
Table 16: North American Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 17: North American Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 18: North American Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 19: North American Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 20: North American Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 21: North American Market for Hemoglobin A1c Testing Devices and Kits, by Country, Through 2028
Table 22: U.S. Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 23: U.S. Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 24: U.S. Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 25: U.S. Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 26: U.S. Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 27: Canadian Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 28: Canadian Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 29: Canadian Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 30: Canadian Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 31: Canadian Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 32: Mexican Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 33: Mexican Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 34: Mexican Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 35: Mexican Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 36: Mexican Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 37: European Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 38: European Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 39: European Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 40: European Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 41: European Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 42: European Market for Hemoglobin A1c Testing Devices and Kits, by Country, Through 2028
Table 43: German Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 44: German Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 45: German Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 46: German Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 47: German Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 48: Italian Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 49: Italian Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 50: Italian Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 51: Italian Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 52: Italian Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 53: French Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 54: French Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 55: French Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 56: French Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 57: French Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 58: U.K. Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 59: U.K. Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 60: U.K. Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 61: U.K. Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 62: U.K. Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 63: Spanish Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 64: Spanish Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 65: Spanish Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 66: Spanish Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 67: Spanish Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 68: Rest of the European Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 69: Rest of the European Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 70: Rest of the European Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 71: Rest of the European Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 72: Rest of the European Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 73: Asia-Pacific Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 74: Asia-Pacific Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 75: Asia-Pacific Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 76: Asia-Pacific Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 77: Asia-Pacific Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 78: Asia-Pacific Market for Hemoglobin A1c Testing Devices and Kits, by Country, Through 2028
Table 79: Japanese Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 80: Japanese Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 81: Japanese Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 82: Japanese Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 83: Japanese Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 84: Indian Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 85: Indian Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 86: Indian Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 87: Indian Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 88: Indian Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 89: Australia & New Zealand Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 90: Australia & New Zealand Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 91: Australia & New Zealand Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 92: Australia & New Zealand Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 93: Australia & New Zealand Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 94: Chinese Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 95: Chinese Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 96: Chinese Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 97: Chinese Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 98: Chinese Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 99: Rest of Asia-Pacific Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 100: Rest of Asia-Pacific Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 101: Rest of Asia-Pacific Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 102: Rest of Asia-Pacific Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 103: Rest of Asia-Pacific Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 104: Rest of World Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 105: Rest of World Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 106: Rest of World Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 107: Rest of World Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 108: Rest of World Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 109: Rest of World Market for Hemoglobin A1c Testing Devices and Kits, by Country, Through 2028
Table 110: Brazilian Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 111: Brazilian Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 112: Brazilian Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 113: Brazilian Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 114: Brazilian Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 115: GCC Countries’ Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 116: GCC Countries’ Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 117: GCC Countries’ Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 118: GCC Countries’ Market for Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 119: GCC Countries’ Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 120: Other RoW Countries’ Market for Hemoglobin A1c Testing Devices and Kits, by Technology, Through 2028
Table 121: Other RoW Countries’ Market for Hemoglobin A1c Testing Devices and Kits, by Chromatography, Through 2028
Table 122: Other RoW Countries’ Market for Hemoglobin A1c Testing Devices and Kits, by Assay Technique, Through 2028
Table 123: Other RoW Countries’ Hemoglobin A1c Testing Devices and Kits, by End User, Through 2028
Table 124: Other RoW Countries’ Market for Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, Through 2028
Table 125: Key ESG Trends in Hemoglobin A1c Testing Devices and Kits Industry
Table 126: Environmental Metrics for Hemoglobin A1c Testing Devices and Kits Manufacturing Industry
Table 127: Social Metrics for Hemoglobin A1c Testing Devices and Kits Manufacturing Industry
Table 128: Governance Metrics for Hemoglobin A1c Testing Devices and Kits Manufacturing Industry
Table 129: Recently Received Awards by Major Companies
Table 130: ESG Rankings for Major Hemoglobin A1c Testing Devices and Kits Companies, 2023*
Table 131: Emerging Trends in Diabetes Medical Devices and Diagnosis Industry
Table 132: Recent Mergers and Acquisitions in the Global Diabetes Therapeutics and Diagnostics Market, 2018-June 2023
Table 133: FDA-approved Products and Point-of-Care Testing Methods: HbA1c Testing Devices and Kits Industry
Table 134: Abbott: Financials, 2022
Table 135: Abbott: HbA1c Testing Devices and Kits Products
Table 136: Abbott: News/Key Developments, 2021-2023
Table 137: Arkray Inc.: HbA1c Testing Devices and Kits Products
Table 138: Arkray Inc.: Strategic Developments, 2017-2022
Table 139: Bayer AG: Financials, 2021 and 2022
Table 140: Bayer AG: News/Key Developments, 2019-2022
Table 141: Bayer AG: HbA1c Testing Devices and Kits Products
Table 142: Bio-Rad Laboratories Inc.: Financials, 2021 and 2022
Table 143: Bio-Rad Laboratories Inc.: News/Key Developments, 2019-2022
Table 144: Bio-Rad Laboratories Inc.: HbA1c Testing Devices and Kits Products
Table 145: Danaher: Financials, 2021 and 2022
Table 146: Danaher: News/Key Developments, 2018-2021
Table 147: Danaher: HbA1c Testing Devices and Kits Products
Table 148: EKF Diagnostics Holdings plc: Financials, 2021 and 2022
Table 149: EKF Diagnostics Holdings Plc: News/Key Developments, 2019-2022
Table 150: EKF Diagnostics Holdings Plc: HbA1c Testing Devices and Kits Products
Table 151: F. Hoffmann-La Roche AG: Financials, 2021 and 2022
Table 152: F. Hoffmann-La Roche AG: News/Key Developments, 2021 and 2022
Table 153: F. Hoffmann-La Roche AG: HbA1c Testing Devices and Kits Products
Table 154: LumiraDx: Financials, 2021 and 2022
Table 155: LumiraDx: News/Key Developments, 2022 and 2023
Table 156: LumiraDx: HbA1c Testing Devices and Kits Products
Table 157: Meril Life Sciences Pvt. Ltd.: HbA1c Testing Devices and Kits Products
Table 158: OSANG Healthcare: Financials, 2021 and 2022
Table 159: OSANG Healthcare: News/Key Developments, 2020-2022
Table 160: OSANG Healthcare: HbA1c Testing Devices and Kits Products
Table 161: Siemens Healthineers: Financials, 2021 and 2022
Table 162: Siemens Healthineers: News/Key Developments, 2019-2023
Table 163: Siemens Healthineers: HbA1c Testing Devices and Kits Products
Table 164: Sinocare: Financials, 2021 and 2022
Table 165: Sinocare: News/Key Developments, 2021 and 2022
Table 166: Sinocare: HbA1c Testing Devices and Kits Products
Table 167: Thermo Fisher Scientific Inc.: Financials, 2021 and 2022
Table 168: Thermo Fisher Scientific Inc.: News/Key Developments, 2019-2022
Table 169: Thermo Fisher Scientific Inc.: HbA1c Testing Devices and Kits Products
Table 170: Trinity Biotech plc: Financials, 2020 and 2021
Table 171: Trinity Biotech plc.: News/Key Developments, 2022 and 2023
Table 172: Trinity Biotech plc.: HbA1c Testing Devices and Kits Products
Table 173: Wuxi BioHermes Biomedical Technology Co. Ltd.: HbA1c Testing Devices and Kits Products
Table 174: Xiamen Biotime Biotechnology Co. Ltd.: News/Key Developments, 2022-2023
Table 175: Xiamen Biotime Biotechnology Co. Ltd.: HbA1c Testing Devices and Kits Products
Table 176: Government Regulatory Agencies and Professional Organizations

List of Figures
Summary Figure: Global Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 1: Global Diabetes Incidence and Projections, 2019-2045
Figure 2: Growing Population Statistics, Worldwide
Figure 3: Barriers to HbA1c Test
Figure 4: Global Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 5: Global Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography Technique, 2022
Figure 6: Uncovering the Ion-Exchange HPLC Advantage
Figure 7: Global Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Techniques, 2022
Figure 8: Global Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 9: Global Market Shares of Hemoglobin A1c Testing Devices and Kits, by POCS, 2022
Figure 10: Global Market Shares of Hemoglobin A1c Testing Devices and Kits, by Region, 2022
Figure 11: North American Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 12: North American Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromtography, 2022
Figure 13: North American Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 14: North American Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 15: North American Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 16: North American Market Shares of Hemoglobin A1c Testing Devices and Kits, by Country, 2022
Figure 17: U.S. Diabetes Prevalence Statistics, 2022
Figure 18: U.S. Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 19: U.S. Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 20: U.S. Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 21: U.S. Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 22: U.S. Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 23: Canadian Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 24: Canadian Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 25: Canadian Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 26: Canadian Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 27: Canadian Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 28: Mexican Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 29: Mexican Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 30: Mexican Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 31: Mexican Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 32: Mexican Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 33: European Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 34: European Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 35: European Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 36: European Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 37: European Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 38: European Market Shares of Hemoglobin A1c Testing Devices and Kits, by Country, 2022
Figure 39: German Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 40: German Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 41: German Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 42: German Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 43: German Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 44: Key Components of the German Statutory Health Insurance System, 2019
Figure 45: Italian Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 46: Italian Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 47: Italian Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 48: Italian Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 49: Italian Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 50: French Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 51: French Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 52: French Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 53: French Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 54: French Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 55: U.K. Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 56: U.K. Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 57: U.K. Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 58: U.K. Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 59: U.K. Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 60: Spanish Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 61: Spanish Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 62: Spanish Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 63: Spanish Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 64: Spanish Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 65: Rest of the European Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 66: Rest of the European Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 67: Rest of the European Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 68: Rest of the European Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 69: Rest of the European Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 70: Asia-Pacific Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 71: Asia-Pacific Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 72: Asia-Pacific Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 73: Asia-Pacific Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 74: Asia-Pacific Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 75: Asia-Pacific Market Shares of Hemoglobin A1c Testing Devices and Kits, by Country, 2022
Figure 76: Japanese Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 77: Japanese Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 78: Japanese Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 79: Japanese Market Shares of Market for Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 80: Japanese Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 81: Indian Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 82: Indian Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 83: Indian Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 84: Indian Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 85: Indian Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 86: Australia & New Zealand Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 87: Australia & New Zealand Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 88: Australia & New Zealand Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 89: Australia & New Zealand Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 90: Australia & New Zealand Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 91: Chinese Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 92: Chinese Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 93: Chinese Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 94: Chinese Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 95: Chinese Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 96: Rest of Asia-Pacific Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 97: Rest of Asia-Pacific Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 98: Rest of Asia-Pacific Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 99: Rest of Asia-Pacific Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 100: Rest of Asia-Pacific Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 101: Rest of World Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 102: Rest of World Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 103: Rest of World Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 104: Rest of World Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 105: Rest of World Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 106: Rest of World Market Shares of Hemoglobin A1c Testing Devices and Kits, by Country, 2022
Figure 107: Brazilian Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 108: Brazilian Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 109: Brazilian Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 110: Brazilian Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 111: Brazilian Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 112: GCC Countries’ Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 113: GCC Countries’ Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 114: GCC Countries’ Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 115: GCC Countries’ Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 116: GCC Countries’ Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 117: Other RoW Countries’ Market Shares of Hemoglobin A1c Testing Devices and Kits, by Technology, 2022
Figure 118: Other RoW Countries’ Market Shares of Hemoglobin A1c Testing Devices and Kits, by Chromatography, 2022
Figure 119: Other RoW Countries’ Market Shares of Hemoglobin A1c Testing Devices and Kits, by Assay Technique, 2022
Figure 120: Other RoW Countries’ Market Shares of Hemoglobin A1c Testing Devices and Kits, by End User, 2022
Figure 121: Other RoW Countries’ Market Shares of Hemoglobin A1c Testing Devices and Kits, by Point of Care Setting, 2022
Figure 122: Snapshot - Key ESG Trends in Hemoglobin A1c Testing Devices and Kits Industry
Figure 123: Abbott’s ESG Priorities Matrix
Figure 124: Bio-Rad Laboratories’ ESG Priorities Matrix
Figure 125: Snapshot - Key Trends in the Growth of Diabetes Medical Devices
Figure 126: Share of Global Diabetes Therapeutics and Diagnostics Market Deal Activity, by Type, 2018-June 2023
Figure 127: Global Diabetes Therapeutics and Diagnostics Market Deal Activity, by Top 10 Industries, 2018-June 2023
Figure 128: Global Market Shares of HbA1c Testing Devices and Kits, by Company, 2022
Figure 129: Global Market Shares of HbA1c Testing Technology Types, by Company, 2022
Figure 130: Abbott: Financials, 2021 and 2022
Figure 131: Abbott: Revenue Share, by Diagnostic Segment, 2022
Figure 132: Abbott: Revenue Share, by Region, 2022
Figure 133: Bayer AG: Financials, 2021 and 2022
Figure 134: Bayer AG: Revenue Share, by Business Unit, 2022
Figure 135: Bayer AG: Revenue Share, by Region, 2022
Figure 136: Bio-Rad Laboratories Inc.: Financials, 2021 and 2022
Figure 137: Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, 2022
Figure 138: Bio-Rad Laboratories Inc.: Revenue Share, by Region, 2022
Figure 139: Danaher: Financials, 2021 and 2022
Figure 140: Danaher: Revenue Share, by Business Unit, 2022
Figure 141: Danaher: Revenue Share, by Region, 2022
Figure 142: EKF Diagnostics Holdings Plc: Financials, 2021 and 2022
Figure 143: EKF Diagnostics Holdings Plc: Revenue Share, by Business Unit, 2022
Figure 144: EKF Diagnostics Holdings Plc: Revenue Shares, by Country/Region, 2022
Figure 145: F. Hoffmann-La Roche AG: Financials, 2021 and 2022
Figure 146: F. Hoffmann-La Roche AG: Revenue Share, by Business Unit, 2022
Figure 147: F. Hoffmann-La Roche AG: Diagnostic Revenue Share, by Region, 2022
Figure 148: LumiraDx: Financials, 2021 and 2022
Figure 149: LumiraDx: Revenue Share, by Business Unit, 2022
Figure 150: LumiraDx: Revenue Share, by Region, 2022
Figure 151: OSANG Healthcare: Financials, 2021 and 2022
Figure 152: Siemens Healthineers: Financials, 2021 and 2022
Figure 153: Siemens Healthineers: Revenue Share, by Business Unit, 2022
Figure 154: Siemens Healthineers: Diagnostic Revenue Shares, by Region, 2022
Figure 155: Sinocare: Financials, 2021 and 2022
Figure 156: Sinocare: Revenue Share, by Business Unit, 2022
Figure 157: Sinocare: Revenue Share, by Country/Region, 2022
Figure 158: Thermo Fisher Scientific Inc.: Financials, 2021 and 2022
Figure 159: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2022
Figure 160: Thermo Fisher Scientific Inc.: Revenue Share, by Region, 2022
Figure 161: Trinity Biotech plc: Financials, 2020 and 2021
Figure 162: Trinity Biotech plc: Revenue Share, by Business Unit, 2021
Figure 163: Trinity Biotech plc: Revenue Share, by Region, 2021

Executive Summary

The global Hemoglobin A1c Testing Devices & Kits Market was valued at $1.9 billion in 2022. The market is expected to grow at a compound annual growth rate (CAGR) of 9.2% to reach $3.2 billion by 2028. Growth of the global market is attributed to factors such as the growing prevalence of diabetes, rising outbreaks of infectious diseases, reoccurrence of high sugar level among people aged between 20 and 70 years, and substantial investment in research and development activities by key market players, including Abbott, Siemens Healthineers, Roche and Bio-Rad Laboratories Inc., among others.

The prevalence of diabetes is growing globally, especially in developing economies like China and India. Diverse factors, including rapid urbanization and sedentary lifestyle development, have been responsible for the rapidly growing prevalence of diabetes, especially in developing economies. The International Federation for Diabetes reported that about 435 million adults suffered from diabetes in 2017, and this number is projected to rise to around 630 million by 2045. China, India, the U.S., Brazil and Mexico account for an estimated 55% to 60% of the global diabetes population according to these studies. Today, China and India account for about 44% of the global population of diabetes.

Other factors contributing to the growing incidence and prevalence of diabetes include obesity and a lack of awareness about the diseases. Rising obesity coupled with growing numbers of patients with diabetes is expected to increase demand for diabetes care and drive growth in the market for diabetes control devices over the forecast period.

Companies Mentioned

  • Abbott
  • Arkray Inc.
  • Bayer AG
  • Bio-Rad Laboratories Inc.
  • Danaher
  • Ekf Diagnostics Holdings plc
  • F. Hoffmann-La Roche AG
  • Lumiradx
  • Meril Life Sciences Private. Ltd.
  • Osang Healthcare Co. Ltd.
  • Siemens Healthcare GmbH
  • Sinocare Inc.
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech plc
  • Wuxi Biohermes Biomedical Technology Co. Ltd.
  • Xiamen Biotime Biotechnology Co. Ltd.

Table Information